{"name":"Kjeld Schmiegelow","slug":"kjeld-schmiegelow","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Xaluprine","genericName":"Xaluprine","slug":"xaluprine","indication":"Acute lymphoid leukemia","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Puri-Nethol","genericName":"Puri-Nethol","slug":"puri-nethol","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Xaluprine","genericName":"Xaluprine","slug":"xaluprine","phase":"marketed","mechanism":"Multidrug resistance-associated protein 4, Multidrug resistance-associated protein 5, Thiopurine S-methyltransferase","indications":["Acute lymphoid leukemia","Acute promyelocytic leukemia, FAB M3"],"catalyst":""},{"name":"Puri-Nethol","genericName":"Puri-Nethol","slug":"puri-nethol","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBveEJkZzhZWlVOdUZ2YnJJT1FvaHNQNHhqTlJzNTVTUXFwbmRFdWlicmFpV2FkZndRY1A1NTY2Y1FBdDdrbUtaYVR4TmRrVFJFaWpKNVpLcktleFVrNFN3?oc=5","date":"2025-12-08","type":"pipeline","source":"Nature","summary":"Role of common host genome variants in Childhood Acute Lymphoblastic Leukemia - Nature","headline":"Role of common host genome variants in Childhood Acute Lymphoblastic Leukemia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBCR3JnNU9xTy05T2QwMjdEUnpEMFgtUVU5S0dyQVcycGdac0dwVmJ6WVBCZ0JwU2o2a2dNQzA2RWJsUkIySWpfX3ZVWkdqMHhOeUVXTlRGNFdPWG5SdXdz?oc=5","date":"2022-06-02","type":"pipeline","source":"Nature","summary":"Maintenance therapy for acute lymphoblastic leukemia: basic science and clinical translations - Nature","headline":"Maintenance therapy for acute lymphoblastic leukemia: basic science and clinical translations","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}